Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$251 Mln
Revenue (TTM)
$6 Mln
Net Profit (TTM)
$0 Mln
ROE
1 %
ROCE
-- %
P/E Ratio
137.5
P/B Ratio
23.9
Industry P/E
--
EV/EBITDA
33.8
Div. Yield
0 %
Debt to Equity
0.3
Book Value
$0.7
EPS
$1.2
Face value
--
Shares outstanding
10,149,411
CFO
$-155.76 Mln
EBITDA
$-142.55 Mln
Net Profit
$-205.86 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
OpGen (OPGN)
| -- | -- | -- | -- | 162.3 | -13.7 | -47.1 |
|
BSE Sensex*
| -14.5 | -10.9 | -15.0 | -4.7 | 7.1 | 7.7 | 11.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
OpGen (OPGN)
| -85.1 | -85.9 | -51.0 | 80.5 | -95.7 | -72.0 | -83.8 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
OpGen (OPGN)
|
24.0 | 251.2 | 5.2 | 12.0 | -156.5 | 162.5 | 137.5 | 23.9 |
| 62.9 | 8,072.9 | 1,091.0 | 202.3 | 31.6 | 31.3 | 36 | 14.2 | |
| 228.2 | 13,405.2 | 691.7 | -219.0 | -13.7 | 163.2 | -- | 14.6 | |
| 66.6 | 7,755.6 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.3 | |
| 44.0 | 11,247.3 | 2,320.1 | 782.6 | 39.0 | 35.5 | 14.9 | 5.0 | |
| 91.2 | 11,306.9 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 55.7 | |
| 7.1 | 6,847.2 | 113.3 | -351.4 | -211.0 | 71.1 | -- | 0.0 | |
| 529.8 | 11,592.5 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 16.8 | |
| 489.5 | 13,063.9 | 2,530.2 | 451.1 | 21.3 | 70.2 | 30.1 | 28.0 | |
| 319.3 | 7,699.1 | 0.0 | -303.3 | -- | -45.8 | -- | 8.8 |
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application... cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland. Read more
Executive VP of Corporate Development
Dr. Oliver Schacht Ph.D.
Executive VP of Corporate Development
Dr. Oliver Schacht Ph.D.
Headquarters
Clarksburg, MD
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of OpGen Inc (OPGN) is $24.00 (NASDAQ) as of 01-Apr-2026 09:30 EDT. OpGen Inc (OPGN) has given a return of 162.29% in the last 3 years.
The P/E ratio of OpGen Inc (OPGN) is 137.50 times as on 27-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
-0.02
|
-0.05
|
|
2022
|
0.00
|
0.01
|
|
2021
|
-0.01
|
0.00
|
The 52-week high and low of OpGen Inc (OPGN) are Rs 24.63 and Rs 20.98 as of 02-Apr-2026.
OpGen Inc (OPGN) has a market capitalisation of $ 251 Mln as on 27-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in OpGen Inc (OPGN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$21.60
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.